Venous Thromboembolism following Two Doses of COVID-19 mRNA Vaccines in the US Population, 2020-2022.

HOME
>
論文・技術情報
>
Venous Thromboembolism following Two Doses of COVID-19 mRNA Vaccines in the US Population, 2020-2022.

アブストラクト	The COVID-19 mRNA vaccine is one of the most effective strategies used to fight against COVID-19. Recently, venous thromboembolism (VTE) events after COVID-19 mRNA vaccination have been reported in various research. Such a concern may hamper the ongoing COVID-19 vaccination campaign. Based on the US Vaccine Adverse Event Reporting System data, this modified self-controlled case series study investigated the association of COVID-19 mRNA vaccination with VTE events among US adults. We found the VTE incidence rate in the recommended dose interval does not change significantly after receiving COVID-19 mRNA vaccines. This conclusion still holds if the analysis is stratified by age and gender. The VTE onset may not be significantly associated with COVID-19 mRNA vaccination.
ジャーナル名	Vaccines
Pubmed追加日	2022/8/27
投稿者	Lai, Daoyuan; Zhang, Yan Dora; Lu, Junfeng
組織名	Department of Statistics and Actuarial Science, Faculty of Science, The;University of Hong Kong, Hong Kong 999077, China.;Centre for PanorOmic Sciences, Li Ka Shing Faculty of Medicine, The University of;Hong Kong, Hong Kong 999077, China.;First Department of Liver Disease, Beijing You'An Hospital, Capital Medical;University, Beijing 100069, China.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/36016205/